Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.37	51.37	31.17	73.98	50.71	71.72
Short-Term Investments	10.11	22.41	73.94	22.52	106.51	151.16
Cash & Short-Term Investments	66.48	73.78	105.11	96.5	157.22	222.88
Cash Growth	-25.12%	-29.81%	8.92%	-38.62%	-29.46%	247.39%
Accounts Receivable	41.58	34.1	12.1	-	-	-
Other Receivables	-	-	-	2.25	31.54	38.44
Receivables	41.58	34.1	12.1	2.25	31.54	38.44
Inventory	20.41	20.3	10.38	-	-	-
Prepaid Expenses	9.96	5.15	4.37	1.52	3.18	1.02
Other Current Assets	0.83	0.88	2.24	0.57	0.55	1.12
Total Current Assets	139.26	134.21	134.2	100.84	192.49	263.45
Property, Plant & Equipment	11.67	12.86	13.08	13.24	11.49	8.16
Goodwill	16.84	16.84	16.84	16.84	16.84	16.84
Long-Term Deferred Tax Assets	-	-	-	-	24.13	18.26
Other Long-Term Assets	0.19	0.34	0.58	1.87	2.33	4.93
Total Assets	167.95	164.24	164.7	132.79	247.27	311.64
Accounts Payable	9.12	7.33	11.43	7.89	7.68	2.93
Accrued Expenses	23.97	24.54	19.45	8.51	12.03	8.68
Current Portion of Long-Term Debt	1.97	1.89	0.73	37.67	-	-
Current Portion of Leases	0.71	0.58	0.93	0.96	0.9	0.47
Other Current Liabilities	15.17	14.49	4.31	0.77	0.39	3.03
Total Current Liabilities	50.93	48.83	36.86	55.79	21	15.11
Long-Term Debt	35.52	35.25	32.76	91.61	142.4	128.21
Long-Term Leases	2.19	1.12	1.69	0.78	1.71	1.84
Other Long-Term Liabilities	5.24	5.18	5.65	5.74	3.92	4.21
Total Liabilities	93.88	90.39	76.96	153.93	169.02	149.37
Common Stock	0.97	0.97	0.9	0.63	0.59	0.58
Additional Paid-In Capital	896.66	891.79	855.45	589.78	549.35	566.92
Retained Earnings	-799.25	-794.33	-745.5	-585.22	-447.76	-384.19
Comprehensive Income & Other	-24.31	-24.58	-23.17	-26.34	-23.94	-21.05
Total Common Equity	74.07	73.85	87.69	-21.15	78.24	162.26
Shareholders' Equity	74.07	73.85	87.74	-21.15	78.24	162.27
Total Liabilities & Equity	167.95	164.24	164.7	132.79	247.27	311.64
Total Debt	40.38	38.84	36.11	131.02	145	130.52
Net Cash (Debt)	26.1	34.93	69	-34.52	12.22	92.36
Net Cash Growth	-48.85%	-49.37%	-	-	-86.77%	-
Net Cash Per Share	0.27	0.37	0.86	-0.57	0.21	1.68
Filing Date Shares Outstanding	96.74	96.63	90.58	64.48	59.03	58.47
Total Common Shares Outstanding	96.63	96.52	89.83	62.88	58.62	58.4
Working Capital	88.33	85.37	97.35	45.05	171.49	248.35
Book Value Per Share	0.77	0.77	0.98	-0.34	1.33	2.78
Tangible Book Value	57.23	57.01	70.85	-37.99	61.4	145.43
Tangible Book Value Per Share	0.59	0.59	0.79	-0.60	1.05	2.49
Machinery	-	0.63	0.63	0.63	0.3	0.3

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q